Lipomeg

Omega-3-Acid Ethyl Esters, the active ingredient in Lipomeg, is a omega-3 fatty acid presented as an oral formulation for oral use. It is used to lower elevated plasma triglyceride concentrations in patients with severe hypertriglyceridaemia.

GNH USA supplies Lipomeg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lipomeg is an omega‑3 fatty acid medication that targets elevated triglyceride metabolism. - Severe hypertriglyceridaemia: reduces plasma triglyceride levels to lower the risk of pancreatitis. - Familial hyperchylomicronaemia: assists in managing extremely high triglycerides when diet alone is insufficient. - Adjunct to lipid‑lowering therapy: complements statins or fibrates to improve overall lipid profile.

Lipomeg may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Fish‑oil aftertaste: a persistent marine taste in the mouth. - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Diarrhoea: loose stools occurring after dosing. - Flatulence: increased intestinal gas. - Headache: mild to moderate pain. - Elevated liver enzymes: mild transaminase rise.

Serious or Rare Side Effects: - Acute pancreatitis: severe abdominal pain requiring medical attention. - Bleeding complications: especially when combined with anticoagulants. - Allergic reactions: rash, pruritus, or anaphylaxis. - Atrial fibrillation: new‑onset irregular heart rhythm. - Severe hepatic injury: marked elevation of liver function tests. - Hyperglycaemia: increased blood glucose levels in susceptible individuals.

Before starting Lipomeg, clinicians should consider several safety measures. - Baseline triglyceride assessment: confirm severe hypertriglyceridaemia. - Liver function monitoring: check transaminases periodically. - Bleeding risk evaluation: review concurrent anticoagulant or antiplatelet therapy. - Fish‑oil allergy screening: avoid use in patients with known hypersensitivity. - Pregnancy and lactation counseling: discuss potential risks with the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lipomeg can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Warfarin: may potentiate anticoagulant effect and increase bleeding risk. - Antiplatelet agents (e.g., clopidogrel): additive bleeding tendency. - High‑dose fibrates: heightened risk of gallstone formation.

Moderate Interactions (Monitor Closely): - Statins: combined use may raise the chance of myopathy. - Other omega‑3 supplements: may lead to excessive omega‑3 exposure. - Cyclosporine: possible increase in serum triglyceride levels.